9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders

(2016) Chonlaphat Sukasem et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents

(2015) Lucia Margari et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys

(2013) Yvette Roke et al.   Pharmacogenetics and Genomics

Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data

(2013) Takashi Tsuboi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study

(2012) Yan Li et al.   CURRENT MEDICAL RESEARCH AND OPINION

Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone

(2012) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents

(2011) Roberto Canitano   Neuropsychiatric Disease and Treatment

A Cross-Sectional Evaluation of the Effect of Risperidone and Selective Serotonin Reuptake Inhibitors on Bone Mineral Density in Boys

(2010) Chadi A. Calarge et al.   JOURNAL OF CLINICAL PSYCHIATRY

Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients

(2010) Yutaro Suzuki et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia

(2010) Norio Yasui-Furukori et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole

(2009) M. M. Rainka et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes

(2009) CHRISTOPH U. CORRELL et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents

(2009) Chadi A. Calarge et al.   Pharmacogenetics and Genomics

Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients

(2008) Norio Yasui-Furukori et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY